Hepatic arterial infusion chemotherapy followed by sorafenib in patients with advanced hepatocellular carcinoma (HICS 55): an open label, non-comparative, phase II trial
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Hepatic arterial infusion chemotherapy followed by sorafenib in patients with advanced hepatocellular carcinoma (HICS 55): an open label, non-comparative, phase II trial ; volume:18 ; number:1 ; day:4 ; month:6 ; year:2018 ; pages:1-10 ; date:12.2018
BMC cancer ; 18, Heft 1 (4.6.2018), 1-10, 12.2018
- Urheber
-
Hatooka, Masahiro
- Beteiligte Personen und Organisationen
-
Kawaoka, Tomokazu
Aikata, Hiroshi
Inagaki, Yuki
Morio, Kei
Nakahara, Takashi
Murakami, Eisuke
Tsuge, Masataka
Hiramatsu, Akira
Imamura, Michio
Kawakami, Yoshiiku
Awai, Kazuo
Masaki, Keiichi
Waki, Koji
Kohno, Hirotaka
Kohno, Hiroshi
Moriya, Takashi
Nagaoki, Yuko
Tamura, Toru
Amano, Hajime
Katamura, Yoshio
Chayama, Kazuaki
SpringerLink (Online service)
- DOI
-
10.1186/s12885-018-4519-y
- URN
-
urn:nbn:de:101:1-2018081022240080446857
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hatooka, Masahiro
- Kawaoka, Tomokazu
- Aikata, Hiroshi
- Inagaki, Yuki
- Morio, Kei
- Nakahara, Takashi
- Murakami, Eisuke
- Tsuge, Masataka
- Hiramatsu, Akira
- Imamura, Michio
- Kawakami, Yoshiiku
- Awai, Kazuo
- Masaki, Keiichi
- Waki, Koji
- Kohno, Hirotaka
- Kohno, Hiroshi
- Moriya, Takashi
- Nagaoki, Yuko
- Tamura, Toru
- Amano, Hajime
- Katamura, Yoshio
- Chayama, Kazuaki
- SpringerLink (Online service)
Ähnliche Objekte (12)
Hepatic Arterial Infusion Chemotherapy versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma
Randomized, phase II trial of sequential hepatic arterial infusion chemotherapy and sorafenib versus sorafenib alone as initial therapy for advanced hepatocellular carcinoma: SCOOP-2 trial
Recurrence After Liver Resection of Colorectal Liver Metastases: Repeat Resection or Ablation Followed by Hepatic Arterial Infusion Pump Chemotherapy
Hepatic artery infusion chemotherapy for advanced hepatocellular carcinoma
Extravasation of a Percutaneous Femoral Hepatic Infusion Device
Correction: Hepatic artery infusion chemotherapy for advanced hepatocellular carcinoma
Hepatic artery infusion pump for nasopharyngeal carcinoma with liver metastasis
Serum HMGB1 concentrations at 4 weeks is a useful predictor of extreme poor prognosis for advanced hepatocellular carcinoma treated with sorafenib and hepatic arterial infusion chemotherapy
Sedation Effects Produced by a Ciprofol Initial Infusion or Bolus Dose Followed by Continuous Maintenance Infusion in Healthy Subjects: A Phase 1 Trial
Preoperative evaluation of accessory hepatic ducts by drip infusion cholangiography with CT
Robotic Versus Open Hepatic Arterial Infusion Pump Placement for Unresectable Intrahepatic Cholangiocarcinoma
Determinants of pain in advanced HCC patients recieving hepatic artery infusion chemotherapy
Hepatic Arterial Infusion Chemotherapy versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma
Randomized, phase II trial of sequential hepatic arterial infusion chemotherapy and sorafenib versus sorafenib alone as initial therapy for advanced hepatocellular carcinoma: SCOOP-2 trial
Recurrence After Liver Resection of Colorectal Liver Metastases: Repeat Resection or Ablation Followed by Hepatic Arterial Infusion Pump Chemotherapy
Hepatic artery infusion chemotherapy for advanced hepatocellular carcinoma
Extravasation of a Percutaneous Femoral Hepatic Infusion Device
Correction: Hepatic artery infusion chemotherapy for advanced hepatocellular carcinoma
Hepatic artery infusion pump for nasopharyngeal carcinoma with liver metastasis
Serum HMGB1 concentrations at 4 weeks is a useful predictor of extreme poor prognosis for advanced hepatocellular carcinoma treated with sorafenib and hepatic arterial infusion chemotherapy
Sedation Effects Produced by a Ciprofol Initial Infusion or Bolus Dose Followed by Continuous Maintenance Infusion in Healthy Subjects: A Phase 1 Trial
Preoperative evaluation of accessory hepatic ducts by drip infusion cholangiography with CT
Robotic Versus Open Hepatic Arterial Infusion Pump Placement for Unresectable Intrahepatic Cholangiocarcinoma
Determinants of pain in advanced HCC patients recieving hepatic artery infusion chemotherapy
Hepatic Arterial Infusion Chemotherapy versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma
Randomized, phase II trial of sequential hepatic arterial infusion chemotherapy and sorafenib versus sorafenib alone as initial therapy for advanced hepatocellular carcinoma: SCOOP-2 trial
Recurrence After Liver Resection of Colorectal Liver Metastases: Repeat Resection or Ablation Followed by Hepatic Arterial Infusion Pump Chemotherapy
Hepatic artery infusion chemotherapy for advanced hepatocellular carcinoma
Extravasation of a Percutaneous Femoral Hepatic Infusion Device
Correction: Hepatic artery infusion chemotherapy for advanced hepatocellular carcinoma
Hepatic artery infusion pump for nasopharyngeal carcinoma with liver metastasis
Serum HMGB1 concentrations at 4 weeks is a useful predictor of extreme poor prognosis for advanced hepatocellular carcinoma treated with sorafenib and hepatic arterial infusion chemotherapy
Sedation Effects Produced by a Ciprofol Initial Infusion or Bolus Dose Followed by Continuous Maintenance Infusion in Healthy Subjects: A Phase 1 Trial
Preoperative evaluation of accessory hepatic ducts by drip infusion cholangiography with CT
Robotic Versus Open Hepatic Arterial Infusion Pump Placement for Unresectable Intrahepatic Cholangiocarcinoma